COMMENT The clinical trial of semagacestat is fascinating because it reported the first disease-modifying drug for Alzheimer’s. The critical question is why the drug made the patients cognitively worse. A number of people have pointed to an off-target effect on ...

CONFERENCE 2015-04-29 00:00:00-2015-05-01 00:00:00 East Midland Conference Centre, Nottingham, U.K. 29 April &#x2013 01 May 2015 The Spring meeting will cover the latest scientific research and the best clinical practice in care of older people. This conference will cover core areas of interest to all ...